Ticagrelor vs prasugrel vs clopidogrel in patients with acute coronary syndromes undergoing therapeutic hypothermia

Trial Profile

Ticagrelor vs prasugrel vs clopidogrel in patients with acute coronary syndromes undergoing therapeutic hypothermia

Completed
Phase of Trial: Phase IV

Latest Information Update: 07 Nov 2013

At a glance

  • Drugs Ticagrelor (Primary) ; Clopidogrel; Prasugrel
  • Indications Acute coronary syndromes
  • Focus Pharmacodynamics
  • Most Recent Events

    • 07 Nov 2013 New trial record
    • 04 Sep 2013 Results presented at the ESC Congress 2013: Annual Congress of the European Society of Cardiology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top